Mushroom-Derived drug targets kidney cancer in dialysis patients
Disease control
Recruiting now
This early-phase trial tests a drug called orellanine in people with advanced kidney cancer who are also on dialysis. The goal is to see if the drug is safe and can shrink tumors. About 75 participants will receive the treatment, and researchers will monitor side effects and canc…
Phase: PHASE1, PHASE2 • Sponsor: Oncorena AB • Aim: Disease control
Last updated May 11, 2026 20:38 UTC